apoA-II Antibodies

Santa Cruz Biotechnology provides a broad selection of apoA-II monoclonal antibodies for various research applications. apoA-II Antibodies are optimized for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Apolipoprotein A-II (apoA-II) plays a crucial role in lipid metabolism and is a key component of high-density lipoprotein (HDL) particles. ApoA-II is involved in the regulation of cholesterol efflux and has been linked to cardiovascular health, making it an important target for research in lipid disorders and atherosclerosis. Understanding apoA-II function can provide insights into the mechanisms of lipid transport and the development of therapeutic strategies for cardiovascular diseases. Research into apoA-II has revealed its significance in maintaining lipid homeostasis and its potential implications in metabolic disorders. Investigating apoA-II interactions with other molecules helps uncover new pathways in lipid metabolism and transport. Characterization of apoA-II continues to yield valuable information about its role in health and disease. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of apoA-II and its impact on human health.